0001209191-16-155969.txt : 20161219
0001209191-16-155969.hdr.sgml : 20161219
20161219172250
ACCESSION NUMBER: 0001209191-16-155969
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161215
FILED AS OF DATE: 20161219
DATE AS OF CHANGE: 20161219
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc.
CENTRAL INDEX KEY: 0001557746
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460571712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SUITE 400, 101 LINDENWOOD DRIVE
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 484-321-5554
MAIL ADDRESS:
STREET 1: SUITE 400, 101 LINDENWOOD DRIVE
CITY: MALVERN
STATE: PA
ZIP: 19355
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Powala Christopher
CENTRAL INDEX KEY: 0001654301
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37581
FILM NUMBER: 162059717
MAIL ADDRESS:
STREET 1: C/O ACLARIS THERAPEUTICS, INC.
STREET 2: 101 LINDENWOOD DRIVE, SUITE 400
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-12-15
0
0001557746
Aclaris Therapeutics, Inc.
ACRS
0001654301
Powala Christopher
C/O ACLARIS THERAPEUTICS, INC.
101 LINDENWOOD DRIVE, SUITE 400
MALVERN
PA
19355
0
1
0
0
Chief Operating Officer
Stock option (right to buy)
28.92
2016-12-15
4
A
0
62400
0.00
A
2026-12-14
Common Stock
62400
62400
D
Restricted stock units
2016-12-15
4
A
0
10400
0.00
A
Common Stock
10400
10400
D
The option will vest over a period of four years, with 25% of the shares underlying the option vesting on the first, second, third and fourth anniversaries of the date of grant.
Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
Subject to the reporting person's continuous service with the issuer as of the applicable vesting date, 50% of the shares underlying these restricted stock units will vest in four equal annual installments beginning on December 15, 2017 and the other 50% of the shares underlying these restricted stock units will vest upon the achievement of a specified commercial milestone.
/s/ Brian F. Leaf, Attorney-in-fact
2016-12-19